XML 28 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2025
Stock-Based Compensation  
Stock-Based Compensation

10.Stock-Based Compensation

Stock Option Activity

A summary of the Company’s stock option activity and related information follows:

Weighted

Average

Weighted-

Remaining

Aggregate

Average

Contractual

Intrinsic Value

    

Shares

    

Exercise Price

    

Term (years)

    

(in thousands)

Outstanding at December 31, 2024

 

6,850,889

$

13.75

 

8.31

$

2,946

Granted

 

4,056,600

$

6.63

Cancelled or forfeited

 

(50,182)

$

10.14

Expired

(289)

$

650.85

Outstanding at March 31, 2025

10,857,018

$

11.09

8.76

$

391

Vested and exercisable at March 31, 2025

3,057,331

$

14.91

7.28

$

281

Vested and expected to vest at March 31, 2025

 

10,857,018

$

11.09

8.76

$

391

There were no options exercised in the three months ended March 31, 2025. The intrinsic value of stock options exercised in the three months ended March 31, 2024 was $0.1 million. The total grant date fair value of stock options vested for the three months ended March 31, 2025 and 2024 was $8.3 million and $3.2 million, respectively. The weighted-average grant date fair value per share of options granted for the three months ended March 31, 2025 and 2024 was $4.64 and $10.40, respectively.

At March 31, 2025, the total unrecognized compensation expense related to unvested stock option awards was $47.8 million. The Company expects to recognize that cost over a weighted-average period of approximately 3.1 years.

Stock-Based Compensation Expense

During the three months ended March 31, 2025 and 2024, the Company recorded stock-based compensation expense for employee and non-employee stock options and restricted stock, which was allocated as follows in the statements of operations (in thousands):

Three Months Ended March 31,

    

2025

    

2024

General and administrative

$

2,537

$

2,050

Research and development

 

1,302

 

704

Total

$

3,839

$

2,754

No related tax benefits were recognized during the three months ended March 31, 2025 and 2024.